Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), in-line with the analyst estimate of ($0.20).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), in-line with the analyst estimate of ($0.20).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.